WHO Outlook on Ending the Acute Phase of the Pandemic
The WHO considers it feasible to end the acute phase of the COVID-19 pandemic in 2022 but emphasizes the importance of continued vigilance, vaccination efforts, and public health measures to prevent resurgence and control the spread of SARS-CoV-2.
September 2022
Reduced Severity of COVID-19 in Fully Vaccinated Individuals: Comparative Analysis
COVID-19 is less severe in fully vaccinated individuals, with lower rates of mechanical ventilation and death observed among vaccinated compared to unvaccinated individuals, underscoring the protective efficacy of vaccination against severe disease outcomes in coronavirus infection.
September 2022
Human Challenge Study with SARS-CoV-2: Exploring Infection Dynamics
The first human challenge study with SARS-CoV-2 investigates the effects of viral infection in volunteers, providing valuable insights into the pathophysiology, immune response, and clinical manifestations of COVID-19, and facilitating the development of novel therapeutics and vaccines.
September 2022
Reduced Intensive Care Needs in Vaccinated Individuals: Cedars-Sinai and CDC Study
A new study from Cedars-Sinai and the CDC demonstrates that vaccinated individuals have reduced need for intensive care during surges of the Omicron and Delta variants, highlighting the effectiveness of vaccination in preventing severe COVID-19 outcomes.
September 2022
Urgent Call for Global Vaccine Action against COVID-19: Addressing Misinformation
Global efforts to combat COVID-19 must prioritize vaccine distribution and address misinformation to ensure equitable access to vaccines and control the spread of the virus, emphasizing the critical role of international cooperation and public health advocacy.
September 2022
Menstruation and COVID-19 Vaccine: Reassuring Observational Data
Two new observational studies provide reassuring data on the safety and efficacy of COVID-19 vaccination in menstruating individuals, addressing concerns and supporting the inclusion of diverse populations in vaccination campaigns.
September 2022
COVID-19 Vaccine Safety in Pregnancy: Reassuring Data from Observational Studies
Reassuring data from observational studies support the safety of the COVID-19 vaccine during pregnancy, providing important insights for pregnant individuals and healthcare providers regarding vaccination decisions and maternal-fetal health outcomes.
September 2022
T Cells from Common Colds and SARS-CoV-2 Infection: Implications for Vaccine Development
Findings on T cells from common colds and SARS-CoV-2 infection provide valuable insights for developing second-generation universal vaccines, highlighting the potential for cross-reactive immunity against diverse coronavirus strains.
August 2022
COVID-19 Vaccine and Menstrual Cycle: Study Findings on Pfizer and Moderna Vaccines
Most vaccinated individuals experienced a small increase in menstrual cycle length, with the Pfizer and Moderna vaccines being the most commonly received, shedding light on potential menstrual cycle changes following COVID-19 vaccination.
August 2022
Long-Lasting Protection Offered by COVID-19 Vaccines: Study Analysis
Analysis of vaccine efficacy data demonstrates long-lasting protection provided by Pfizer, Moderna, and Johnson & Johnson COVID-19 vaccines, supporting the ongoing vaccination efforts and public health strategies to control the spread of SARS-CoV-2.
August 2022
